INTA:NASDAQIntapp, Inc. Analysis
Data as of 2026-08-17 - not real-time
$40.11
Latest Price
8/10Risk
Risk Level: High
Executive Summary
At $40.11, Intapp, Inc. shows no decisive moving-average alignment, leaving the trend neutral. The last 30 days have gained 52.2%. RSI sits at 76.7, which reads as overbought, and MACD momentum is bullish. Recent trading has carved out support near $25.56 and resistance around $41.38.
Valuation screens as fair: a P/E of 20.5 sits below the sector average of 36.5. Revenue is growing at 13.0% on a -7.1% profit margin.
The composite risk read is 8/10, putting it in high territory. With 30-day volatility of 57.9%, a beta of 0.42 and a maximum drawdown of 59.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.
Valuation screens as fair: a P/E of 20.5 sits below the sector average of 36.5. Revenue is growing at 13.0% on a -7.1% profit margin.
The composite risk read is 8/10, putting it in high territory. With 30-day volatility of 57.9%, a beta of 0.42 and a maximum drawdown of 59.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.
Top Market Events
Updated Jul 21, 2026 0 PALO ALTO, Calif.-- BUSINESS WIRE --Jul 21, 2026-- Intapp, Inc., NASDAQ: INTA , the leading...PALO ALTO, Calif., August 04, 2026--Intapp, Inc. NASDAQ: INTA , the leading governed AI platform for professional firms...PALO ALTO, Calif., July 21, 2026--Intapp, Inc., NASDAQ: INTA , the leading governed AI platform for professional firms...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- RSI at 76.7 signals overbought conditions
- Trading above the 200-day average of 30.77
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- RSI at 76.7 signals overbought conditions
- P/E of 20.5 versus sector average of 36.5
- Trading above the 200-day average of 30.77
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 20.5 versus sector average of 36.5
- Negative profit margin of -7.1%
- Negative return on equity of -9.9%
Key Metrics & Analysis
Financial Health
Revenue Growth13.00%
Profit Margin-7.15%
P/E Ratio20.5
ROE-9.87%
ROA-2.18%
Debt/Equity7.19
P/B Ratio9.7
Op. Cash Flow$146.8M
Free Cash Flow$161.4M
Industry P/E36.5
Technical Analysis
TrendNeutral
RSI76.7
Support$25.56
Resistance$41.38
MA 20$32.97
MA 50$28.22
MA 200$30.77
MACDBullish
VolumeIncreasing
Fear & Greed Index95.98
Valuation
Fair Value$48.68
Target Price$39.43
Upside/Downside-1.70%
GradeFair
TypeGrowth
Risk Assessment
Beta0.42
Volatility57.88%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.